Breaking News Instant updates and real-time market news.

APYX

Apyx Medical

$7.22

0.24 (3.44%)

19:39
11/11/19
11/11
19:39
11/11/19
19:39

Apyx Medical price target raised to $10 from $8 at Piper Jaffray

Piper Jaffray analyst Matt O'Brien raised his price target on Apyx Medical to $10 and kept his Overweight rating after its better than expected Q3 results and "conservative" guidance. The analyst cites the management indicating that that the Advanced Energy segment strength was broad-based with the addition of more customers and deeper penetration with existing accounts. O'Brien adds that Apyx management has indicated that it is on track with new indications for Renuvion, which should drive "significant revenue growth for the business in the coming quarters and years".

  • 11

    Nov

  • 12

    Nov

APYX Apyx Medical
$7.22

0.24 (3.44%)

03/14/19
PIPR
03/14/19
NO CHANGE
Target $10
PIPR
Overweight
Apyx Medical posted another solid quarter, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien says Apyx Medical posted another solid quarter in-line with its preannouncement, highlighted by "strong advanced energy growth off a tough comp." While the company's expense guidance may make the earnings outlook a little less favorable in the near-term, given the light penetration into this $1.5B market and the potential for several international expansions in 2019, its growth "should remain healthy for many years," O'Brien tells investors in a research note. He encourages risk tolerant investors to own the name and reiterates an Overweight rating on Apyx Medical with a $10 price target.
04/02/19
PIPR
04/02/19
NO CHANGE
Target $10
PIPR
Overweight
Piper continues to believe Apyx Medical will receive 510k clearance
Apyx Medical's decision to withdraw its 510k submission for dermal resurfacing following FDA pushback on various aspects of their study removes a source of upside and will "no doubt give legs to some of the theories floated in the short report," Piper Jaffray analyst Matt O'Brien tells investors in a research note. However, the analyst continues to believe that once Apyx "irons out" some of its clinical hurdles, the company will receive this clearance. Additionally, O'Brien feels that the product's use off-label for these procedures is likely reflective of J-Plasma's "unique utility in these situations," which allows him to remain constructive on the stock. He reiterates an Overweight rating on Apyx Medical with a $10 price target.
04/02/19
JMPS
04/02/19
NO CHANGE
Target $8
JMPS
Outperform
Apyx Medical price target lowered to $8 from $12 at JMP Securities
JMP Securities analyst David Turkaly lowered his price target on Apyx Medical shares to $8 from $12 after the company said it will voluntarily withdraw its 510(k) application for the use of its Renuvion product in dermal resurfacing procedures. Despite his belief that negative investor sentiment could be priced into the stock in the near-term, Turkaly said Apyx is still a significant grower and he still expects over 50% revenue growth in both 2019 and 2020, leading him to keep an Outperform rating on the shares.
05/08/19
PIPR
05/08/19
NO CHANGE
Target $7
PIPR
Overweight
Apyx Medical price target lowered to $7 from $10 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien lowered his price target on Apyx Medical to $7 after its Q1 results, adjusting his model after the company indicated that its pursuit of a dermal resurfacing indication with the FDA would be outside of the 2019 timeline. The analyst keeps his Overweight rating however and expects Apyx Medical's growth to remain healthy thanks to its "international expansion and core utilization in the US."

TODAY'S FREE FLY STORIES

11:09
12/12/19
12/12
11:09
12/12/19
11:09
General news
5-Yr TIPS Announcement CUSIP Number data reported »

5-Yr TIPS Announcement…

11:09
12/12/19
12/12
11:09
12/12/19
11:09
General news
5-Yr TIPS Announcement Offering Amount data reported »

5-Yr TIPS Announcement…

EH

Ehang

$0.00

(0.00%)

11:09
12/12/19
12/12
11:09
12/12/19
11:09
Syndicate
Breaking Syndicate news story on Ehang »

Ehang opens at $12.55,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

SHAK

Shake Shack

$59.20

0.29 (0.49%)

11:05
12/12/19
12/12
11:05
12/12/19
11:05
Options
Shake Shack call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

MCK

McKesson

$144.02

0.62 (0.43%)

11:02
12/12/19
12/12
11:02
12/12/19
11:02
Hot Stocks
McKesson selected to continue as prime pharmaceutical supplier for VA »

McKesson Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$146.49

2.42 (1.68%)

10:58
12/12/19
12/12
10:58
12/12/19
10:58
Downgrade
Caterpillar rating change  »

Caterpillar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

BILL

Bill.com

$0.00

(0.00%)

10:58
12/12/19
12/12
10:58
12/12/19
10:58
Syndicate
Breaking Syndicate news story on Bill.com »

Bill.com indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

EH

Ehang

$0.00

(0.00%)

10:58
12/12/19
12/12
10:58
12/12/19
10:58
Syndicate
Breaking Syndicate news story on Ehang »

Ehang indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BBU

Brookfield Business Partners

$40.99

(0.00%)

, GNW

Genworth

$4.60

0.135 (3.03%)

10:55
12/12/19
12/12
10:55
12/12/19
10:55
Hot Stocks
Genworth completes Genworth MI Canada stake sale to Brookfield Business Partners »

Genworth Financial (GNW)…

BBU

Brookfield Business Partners

$40.99

(0.00%)

GNW

Genworth

$4.60

0.135 (3.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

10:55
12/12/19
12/12
10:55
12/12/19
10:55
General news
Treasury 30-year auction outlook: the $16 B reopening rounds out this week's auctions »

Treasury 30-year auction…

TSLA

Tesla

$359.21

6.81 (1.93%)

10:51
12/12/19
12/12
10:51
12/12/19
10:51
Periodicals
Tesla loses third general counsel this year, Bloomberg Law says »

Jonathan Chang, who was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

GE

General Electric

$11.42

0.44 (4.01%)

10:46
12/12/19
12/12
10:46
12/12/19
10:46
On The Fly
GE jumps as UBS predicts positive inflection point in 2020 »

Shares of General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BILL

Bill.com

$0.00

(0.00%)

10:45
12/12/19
12/12
10:45
12/12/19
10:45
Syndicate
Breaking Syndicate news story on Bill.com »

Bill.com indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ABBV

AbbVie

$88.15

1.46 (1.68%)

10:45
12/12/19
12/12
10:45
12/12/19
10:45
Options
AbbVie call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/12/19
12/12
10:45
12/12/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
12/12/19
12/12
10:45
12/12/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
12/12/19
12/12
10:45
12/12/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
12/12/19
12/12
10:45
12/12/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

SBUX

Starbucks

$88.83

2.24 (2.59%)

, BHC

Bausch Health

$31.07

1.745 (5.95%)

10:44
12/12/19
12/12
10:44
12/12/19
10:44
On The Fly
GE, Starbucks, Bausch upgrades among today's top analyst calls »

Check out today's top…

SBUX

Starbucks

$88.83

2.24 (2.59%)

BHC

Bausch Health

$31.07

1.745 (5.95%)

AAPL

Apple

$271.38

0.67 (0.25%)

HD

Home Depot

$213.65

1.69 (0.80%)

MMM

3M

$170.04

1.31 (0.78%)

GE

General Electric

$11.42

0.44 (4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Dec

  • 29

    Jan

  • 29

    Jan

  • 25

    Feb

EH

Ehang

$0.00

(0.00%)

10:39
12/12/19
12/12
10:39
12/12/19
10:39
Syndicate
Ehang indicated to open at $12.25, IPO priced at $12.50 »

Ehang (EH) 3.2M share IPO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

WDDMF

WeedMD

$0.00

(0.00%)

, ACB

Aurora Cannabis

$2.46

(0.00%)

10:37
12/12/19
12/12
10:37
12/12/19
10:37
On The Fly
Rising High: An exclusive talk with medical-grade cannabis producer WeedMD »

In this edition of…

WDDMF

WeedMD

$0.00

(0.00%)

ACB

Aurora Cannabis

$2.46

(0.00%)

TLRY

Tilray

$18.68

0.49 (2.69%)

ZYNE

Zynerba

$5.68

0.06 (1.07%)

CGC

Canopy Growth

$20.35

0.05 (0.25%)

CTST

CannTrust

$0.81

-0.0102 (-1.24%)

CRON

Cronos Group

$6.89

0.07 (1.03%)

IGC

India Globalization Capital

$0.67

0.0047 (0.71%)

CVSI

CV Sciences

$0.00

(0.00%)

CANN

General Cannabis

$0.00

(0.00%)

TCNNF

Trulieve Cannabis

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

  • 17

    Dec

PTVCA

Protective Insurance

$15.36

(0.00%)

10:36
12/12/19
12/12
10:36
12/12/19
10:36
Hot Stocks
Breaking Hot Stocks news story on Protective Insurance »

Protective Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$178.55

-1.315 (-0.73%)

10:35
12/12/19
12/12
10:35
12/12/19
10:35
Options
Autodesk put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILL

Bill.com

$0.00

(0.00%)

10:35
12/12/19
12/12
10:35
12/12/19
10:35
Syndicate
Breaking Syndicate news story on Bill.com »

Bill.com indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

USO

United States Oil Fund

$12.45

0.16 (1.30%)

10:34
12/12/19
12/12
10:34
12/12/19
10:34
General news
EIA natural gas storage change for week ending December 6 »

Gas inventories 73 Bcf…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.